Medico Remedies Secures INR 73 Crore Order from UP Medical Supplies
Filing Summary
Medico Remedies Ltd has received an order valued at approximately INR 73 Crore from Uttar Pradesh Medical Supplies Corporation Limited. The order involves the supply of Azithromycin 500mg tablets. The company is required to complete the delivery by October 31, 2026. This order is part of the centralized purchase and distribution efforts by the Uttar Pradesh government entity. Medico Remedies has confirmed that there is no related party transaction involved in this contract. The order is domestic, with no interest from the promoter group in the awarding entity.
Medico Remedies Ltd has announced the receipt of a government supply order valued at approximately INR 73,23,16,646 from Uttar Pradesh Medical Supplies Corporation Limited. The order is for the supply of Azithromycin 500mg tablets. The company is required to fulfill the order by October 31, 2026.
The order was awarded by a domestic entity, Uttar Pradesh Medical Supplies Corporation Limited, which is responsible for the centralized purchase and distribution of medicines and health supplies for the Government of Uttar Pradesh. The order does not involve any related party transactions, and there is no interest from the promoter group in the awarding entity.
The significant terms and conditions of the order are as per the contract. Medico Remedies Ltd will supply the specified quantity of Azithromycin tablets within the stipulated timeline. The order is part of the efforts by the Uttar Pradesh government to ensure timely and effective healthcare services.
Uttar Pradesh Medical Supplies Corporation Limited is a government entity focused on the centralized procurement and distribution of medical supplies. It aims to streamline the supply chain for medicines and health supplies across the state, ensuring efficient healthcare delivery.
Medico Remedies Ltd is engaged in the manufacturing and supply of pharmaceutical products. The company focuses on expanding its market presence through strategic supply contracts and enhancing its product portfolio to meet the growing demand in the healthcare sector.